Literature DB >> 2290157

Major clinical diagnoses found among patients with Raynaud phenomenon from the general population.

H R Maricq1, A R McGregor, F Diat, E A Smith, D B Maxwell, E C LeRoy, M C Weinrich.   

Abstract

This study of 62 individuals with Raynaud phenomenon (RP) drawn from the general population of South Carolina shows a profile of associated diseases that is different from the one reported from hospital based studies. We found that connective tissue diseases affect a much smaller fraction of patients with RP than previously reported. Compared to RP negative controls, our RP positive group was found to suffer more frequently from a variety of diseases, both RP related and not RP related.

Entities:  

Mesh：

Year:  1990        PMID： 2290157

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  8 in total

1.  Serum levels of leptin receptor in patients with systemic sclerosis.

Authors:  Yukimi Ohyoshi; Takamitsu Makino; Masatoshi Jinnin; Wakana Nakayama; Satoshi Fukushima; Yuji Inoue; Hironobu Ihn
Journal:  Intractable Rare Dis Res       Date:  2013-05

2.  Association between endothelial function and microvascular changes in patients with secondary Raynaud's phenomenon.

Authors:  Ji Hyun Le; Kyoung Im Cho
Journal:  Clin Rheumatol       Date:  2014-03-11       Impact factor: 2.980

3.  Serum levels of soluble CD163 in patients with systemic sclerosis.

Authors:  Wakana Nakayama; Masatoshi Jinnin; Katsunari Makino; Ikko Kajihara; Takamitsu Makino; Satoshi Fukushima; Yuji Inoue; Hironobu Ihn
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 4.  Unfolding the pathogenesis of scleroderma through genomics and epigenomics.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  J Autoimmun       Date:  2017-05-16       Impact factor: 7.094

5.  Comparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis.

Authors:  Marcelo Ju Correa; Luis Ec Andrade; Cristiane Kayser
Journal:  Arthritis Res Ther       Date:  2010-08-10       Impact factor: 5.156

6.  Clinical evaluation of scleroderma spectrum disorders using a points system.

Authors:  H Ihn; S Sato; T Tamaki; Y Soma; T Tsuchida; Y Ishibashi; K Takehara
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

7.  Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis.

Authors:  Hideo Kudo; Masatoshi Jinnin; Yoshihide Asano; Maria Trojanowska; Wakana Nakayama; Kuniko Inoue; Noritoshi Honda; Ikko Kajihara; Katsunari Makino; Satoshi Fukushima; Hironobu Ihn
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

8.  Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort.

Authors:  Paul J Nietert; Stephanie R Shaftman; Richard M Silver; Bethany J Wolf; Brent M Egan; Kelly J Hunt; Edwin A Smith
Journal:  Clin Epidemiol       Date:  2015-02-03       Impact factor: 4.790
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.